Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
697
+160
+30% +$67.3K 0.01% 385
2026
Q1
$203K Sell
537
-436
-45% -$187K 0.01% 457
2025
Q4
$416K Sell
973
-14
-1% -$6.09K 0.02% 346
2025
Q3
$442K Buy
+987
New +$447K 0.02% 336

Other funds holding CHE

Equitable Trust's CHE Position: Q2 2026 in Review

Equitable Trust increased its Chemed (CHE) stake by 30% in Q2 2026, buying an estimated $67.3K and bringing the position to 697 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #385.

Equitable Trust first reported a position in CHE in Q3 2025 and has held it in 4 quarters since. The position peaked at $442K in Q3 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Equitable Trust held 697 shares of Chemed worth $325K as of Q2 2026.
  • Equitable Trust bought 160 Chemed shares in Q2 2026, an estimated $67.3K.
  • Chemed made up 0.01% of Equitable Trust's portfolio in Q2 2026, its #385 holding.
  • Equitable Trust first reported a position in Chemed in Q3 2025 and has held it in 4 quarters since.
  • Equitable Trust's Chemed position peaked at $442K in Q3 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.